Artemisinin
Artemisinin is extracted from Artemisia Annua. Stanford Chemicals has been providing quality Artemisinin and many other natural plant extract for over 15 years.
Product Name | Artemisinin |
CAS No. | 63968-64-9 |
Molecular Formula | C15H22O5 |
Molecular Weight | 282.33 |
Botanical Source | Artemisia Annua |
Purity | 99% HPLC |
Appearance | White powder |
Package | 25 kg/drum |
Storage | Stored in cool & dry places, protected from direct sunlight and heat. |
Shelf Life | 2 years |
Artemisinin Safety Tips
Handling of Artemisinin should only be performed by personnel trained and familiar with handling of potent active pharmaceutical ingredients. Moderate to severe irritant to the skin and eyes.
Related Products
-
Product Name: Dihydroartemisinin
CAS No.: 81496-82-4
Molecular Formula: C15H24O5
Molecular Weight: 284.35
Purity: 98% HPLC
Package: 25 kg/drum
-
Artemisia Annua Extract, Specification: 99% Artemisinin HPLC . Botanical Source: Artemisia Annua.
References
- 1. Insecticide resistance in mosquitoes and failure of malaria control.
Brouqui P, Parola P, Raoult D.Expert Rev Anti Infect Ther. 2012 Dec;10(12):1379-81. doi: 10.1586/eri.12.141.
- 2. Anti-allergic action of anti-malarial drug artesunate in experimental mast cell-mediated anaphylactic models.
Cheng C, Ng DS, Chan TK, Guan SP, Ho WE, Koh AH, Bian JS, Lau HY, Wong WS.Allergy. 2012 Dec 18. doi: 10.1111/all.12077. [Epub ahead of print]
- 3. [In vitro antitumor activities and mechanisms of galactosylated artemisinin].
Ren YR.Zhong Yao Cai. 2012 Jul;35(7):1116-20. Chinese.
- 4. An Endophytic Pseudonocardia Species Induces the Production of Artemisinin in Artemisia annua.
Li J, Zhao GZ, Varma A, Qin S, Xiong Z, Huang HY, Zhu WY, Zhao LX, Xu LH, Zhang S, Li WJ.PLoS One. 2012;7(12):e51410. doi: 10.1371/journal.pone.0051410. Epub 2012 Dec 12.
- 5. Genetic loci associated with delayed clearance of Plasmodium falciparum following artemisinin treatment in Southeast Asia.
Takala-Harrison S, Clark TG, Jacob CG, Cummings MP, Miotto O, Dondorp AM, Fukuda MM, Nosten F, Noedl H, Imwong M, Bethell D, Se Y, Lon C, Tyner SD, Saunders DL, Socheat D, Ariey F, Phyo AP, Starzengruber P, Fuehrer HP, Swoboda P, Stepniewska K, Flegg J, Arze C, Cerqueira GC, Silva JC, Ricklefs SM, Porcella SF, Stephens RM, Adams M, Kenefic LJ, Campino S, Auburn S, Macinnis B, Kwiatkowski DP, Su XZ, White NJ, Ringwald P, Plowe CV.Proc Natl Acad Sci U S A. 2012 Dec 17. [Epub ahead of print]
- 6. Antimalarial activity of 10-alkyl/aryl esters and -aminoethylethers of artemisinin.
Cloete TT, Krebs HJ, Clark JA, Connelly MC, Orcutt A, Sigal MS, Kiplin Guy R, N'da DD.Bioorg Chem. 2012 Nov 3;46C:10-16. doi: 10.1016/j.bioorg.2012.10.002. [Epub ahead of print]
- 7. Comparative functional analysis of CYP71AV1 natural variants reveals an important residue for the successive oxidation of amorpha-4,11-diene.
Komori A, Suzuki M, Seki H, Nishizawa T, Meyer JJ, Shimizu H, Yokoyama S, Muranaka T.FEBS Lett. 2012 Dec 12. doi:pii: S0014-5793(12)00905-2. 10.1016/j.febslet.2012.11.031. [Epub ahead of print]
- 8. Electrocardiographic study in Ghanaian children with uncomplicated malaria, treated with artesunate-amodiaquine or artemether-lumefantrine.
Adjei GO, Oduro-Boatey C, Rodrigues OP, Hoegberg LC, Alifrangis M, Kurtzhals JA, Goka BQ.Malar J. 2012 Dec 17;11(1):420. [Epub ahead of print]
- 9. Plasmodium falciparum Malaria in Infants Under 5 Kg: Retrospective Surveillance of Hospital Records in Five Sub-Saharan African Countries.
Alao MJ, Gbadoé AD, Meremikwu M, Tshefu A, Tiono AB, Cousin M, Hamed K.J Trop Pediatr. 2012 Dec 12. [Epub ahead of print]
- 10. Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common.
White NJ, Qiao LG, Qi G, Luzzatto L.Malar J. 2012 Dec 14;11(1):418. [Epub ahead of print]
- 11. [Anti-inflammatory effect and mechanism of artemisinin and dihydroartemisinin].
Yu WY, Kan WJ, Yu PX, Li MM, Song JS, Zhao F.Zhongguo Zhong Yao Za Zhi. 2012 Sep;37(17):2618-21. Chinese.
- 12. Potential drug-drug interactions in HIV-infected children on highly active antiretroviral therapy in Lagos, Nigeria.
Oshikoya K, Lawal S, Oreagba I, Ezeaka C, Temiye E, Adeyemo T.J Int AIDS Soc. 2012 Nov 11;15(6):18363. doi: 10.7448/IAS.15.6.18363.
- 13. Open-label trial of three dosage regimens of fixeddose combination of artemisinin and naphthoquine for treating uncomplicated falciparum malaria in calabar, Nigeria.
Meremikwu MM, Odey F, Oringanje C, Oyo-Ita A, Effa E, Esu EB, Eyam E, Oduwole O, Asiegbu V, Alaribe A, Ezedinachi EN.Malar J. 2012 Dec 11;11(1):413. [Epub ahead of print]
- 14. Scaling-up malaria treatment: a review of the performance of different providers.
Kamal-Yanni MM, Potet J, Saunders PM.Malar J. 2012 Dec 12;11(1):414. [Epub ahead of print]
- 15. The effect of single nucleotide polymorphisms in cytochrome P450 isoenzyme and N-acetyltransferase-2 genes on the metabolism of artemisinin-based combination therapies in malaria patients from Cambodia and Tanzania.
Hodel EM, Csajka C, Ariey F, Guidi M, Kabanywanyi AM, Duong S, Decosterd LA, Olliaro P, Beck HP, Genton B.Antimicrob Agents Chemother. 2012 Dec 10. [Epub ahead of print]
- 16. Transitioning from malaria control to elimination: the vital role of ACTs.
Grueninger H, Hamed K.Trends Parasitol. 2012 Dec 7. doi:pii: S1471-4922(12)00195-X. 10.1016/j.pt.2012.11.002. [Epub ahead of print]
- 17. Efficacy and safety of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in endemic countries: meta-analysis of randomised controlled studies.
Naing C, Mak JW, Aung K, Wong JY.Trans R Soc Trop Med Hyg. 2012 Dec 4. [Epub ahead of print]
- 18. Reduction of multiplicity of infections but no change in msp2 genetic diversity in Plasmodium falciparum isolates from Congolese children after introduction of artemisinin-combination therapy.
Ibara-Okabande R, Koukouikila-Koussounda F, Ndounga M, Vouvoungui J, Malonga V, Casimiro PN, Ibara JR, Sidibe A, Ntoumi F.Malar J. 2012 Dec 7;11(1):410. [Epub ahead of print]
- 19. Efficacy of artemether-lumefantrine as a treatment for uncomplicated Plasmodium vivax malaria in eastern Sudan.
Abdallah TM, Ali AA, Bakri M, Gasim GI, Musa IR, Adam I.Malar J. 2012 Dec 5;11:404. doi: 10.1186/1475-2875-11-404.
- 20. Anti-malarial drug safety information obtained through routine monitoring in a rural district of South-Western Senegal.
Brasseur P, Vaillant MT, Olliaro PL.Malar J. 2012 Dec 5;11(1):402. [Epub ahead of print]